JP2021502816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502816A5 JP2021502816A5 JP2020526478A JP2020526478A JP2021502816A5 JP 2021502816 A5 JP2021502816 A5 JP 2021502816A5 JP 2020526478 A JP2020526478 A JP 2020526478A JP 2020526478 A JP2020526478 A JP 2020526478A JP 2021502816 A5 JP2021502816 A5 JP 2021502816A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell population
- antibody
- engineered
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762586782P | 2017-11-15 | 2017-11-15 | |
| US62/586,782 | 2017-11-15 | ||
| PCT/US2018/061384 WO2019099744A1 (en) | 2017-11-15 | 2018-11-15 | METHODS FOR SELECTIVE EXPANSION OF δ3 γδ T-CELL POPULATIONS AND COMPOSITIONS THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502816A JP2021502816A (ja) | 2021-02-04 |
| JP2021502816A5 true JP2021502816A5 (https=) | 2021-12-23 |
Family
ID=64755702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526478A Pending JP2021502816A (ja) | 2017-11-15 | 2018-11-15 | δ３γδＴ細胞集団の選択的増殖方法及びその組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12221480B2 (https=) |
| EP (1) | EP3710472A1 (https=) |
| JP (1) | JP2021502816A (https=) |
| KR (1) | KR20200098518A (https=) |
| CN (1) | CN111801349A (https=) |
| AU (1) | AU2018370120C1 (https=) |
| CA (1) | CA3082818A1 (https=) |
| IL (1) | IL274640B2 (https=) |
| MX (1) | MX2020005005A (https=) |
| SG (1) | SG11202004506WA (https=) |
| WO (1) | WO2019099744A1 (https=) |
| ZA (1) | ZA202003097B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202105860QA (en) | 2018-12-03 | 2021-07-29 | Adicet Bio Inc | Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof |
| WO2020220016A1 (en) * | 2019-04-26 | 2020-10-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Artificial antigen presenting cells comprising ligands for nkg2d for expanding immune cells for immunotherapy |
| MX2022006547A (es) * | 2019-12-03 | 2022-08-19 | Adicet Bio Inc | Métodos para la expansión de poblaciones de células t gamma delta con agentes multivalentes y composiciones de estas. |
| WO2023069322A1 (en) * | 2021-10-20 | 2023-04-27 | University Of Pittsburgh – Of The Commonwealth System Of Higher Education | Methods and materials for expanding tumor infiltrating gamma-delta t cells |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185250A (en) | 1986-07-03 | 1993-02-09 | T Cell Sciences, Inc. | Human γ, δT cell antigen receptor polypeptides and nucleic acids |
| US5260223A (en) | 1986-07-03 | 1993-11-09 | President & Fellows Of Harvard College | Methods for detection of human gamma, γ T cell receptor |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP0633943A4 (en) | 1992-04-03 | 1997-05-02 | Alexander T Young | GENTHERAPY USING TARGETED VIRAL VECTORS. |
| CA2110946A1 (en) | 1992-12-09 | 1994-06-10 | Elazar Rabbani | Induction of immunocompatibility by nucleic acid |
| AU783250B2 (en) | 1999-06-17 | 2005-10-06 | Dartmouth College | Autologous adoptive immunotherapy with primed antigen-specific T cells or B cells |
| WO2001022816A1 (en) | 1999-09-30 | 2001-04-05 | National Jewish Medical And Research Center | MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| US6737398B1 (en) | 1999-09-30 | 2004-05-18 | National Jewish Medical And Research Center | Modulation of γδ T cells to regulate airway hyperresponsiveness |
| WO2003087341A2 (en) | 2002-01-23 | 2003-10-23 | The University Of Utah Research Foundation | Targeted chromosomal mutagenesis using zinc finger nucleases |
| CN1306027C (zh) | 2002-12-12 | 2007-03-21 | 中国医学科学院基础医学研究所 | 一种体外扩增γδT淋巴细胞的方法 |
| US20060205089A1 (en) | 2003-04-14 | 2006-09-14 | Montana State University | Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications |
| US7985739B2 (en) | 2003-06-04 | 2011-07-26 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced sleeping beauty transposon system and methods for using the same |
| CA2569509C (en) | 2004-06-03 | 2014-08-12 | Novimmune S.A. | Anti-cd3 antibodies and methods of use thereof |
| US7340913B2 (en) | 2004-08-05 | 2008-03-11 | Manitowoc Foodservice Companies, Inc. | Ice machine and ice-making assembly including a water distributor |
| US20080026986A1 (en) | 2006-06-05 | 2008-01-31 | Rong-Fu Wang | Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling |
| JP2010502224A (ja) | 2006-09-08 | 2010-01-28 | アボット・ラボラトリーズ | インターロイキン１３結合タンパク質 |
| WO2010027797A1 (en) | 2008-08-26 | 2010-03-11 | Macrogenics Inc. | T-cell receptor antibodies and methods of use thereof |
| MX336846B (es) | 2010-01-22 | 2016-02-03 | Sangamo Biosciences Inc | Alteracion genomica dirigida. |
| AU2011281062B2 (en) | 2010-07-21 | 2015-01-22 | Board Of Regents, The University Of Texas System | Methods and compositions for modification of a HLA locus |
| MX2013011363A (es) | 2011-04-01 | 2014-04-25 | Sloan Kettering Inst Cancer | Anticuerpos para peptidos citosolicos. |
| PT2710123T (pt) | 2011-05-19 | 2017-10-13 | Inst De Medicina Molecular | Linha celular de linfócitos compreendendo células t gama-delta, método de composição e produção resultante dos mesmos |
| US10391126B2 (en) | 2011-11-18 | 2019-08-27 | Board Of Regents, The University Of Texas System | CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA |
| KR101764096B1 (ko) | 2011-11-28 | 2017-08-02 | 메르크 파텐트 게엠베하 | 항-ｐｄ-ｌ1 항체 및 그의 용도 |
| EP2684600A1 (en) | 2012-07-10 | 2014-01-15 | Laboratoires Meiners Sarl | Core-shell capsules and methods for encapsulation of reactive ingredients by diffusional exchange through spherical capsule membranes |
| JP2016501013A (ja) | 2012-11-08 | 2016-01-18 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | γδＴ細胞の無ＩＬ−２増殖を誘導するための方法 |
| CN102994448A (zh) | 2012-12-13 | 2013-03-27 | 上海柯莱逊生物技术有限公司 | 一种体外扩增γδT细胞的方法 |
| WO2014134412A1 (en) | 2013-03-01 | 2014-09-04 | Regents Of The University Of Minnesota | Talen-based gene correction |
| EP3060059A4 (en) | 2013-10-25 | 2017-11-01 | Board of Regents, The University of Texas System | Polyclonal gamma delta t cells for immunotherapy |
| DK3129404T3 (da) | 2014-04-10 | 2026-04-20 | Lava Therapeutics N V | Immunglobuliner, der binder humane vgamma9vdelta2-t-cellereceptorer |
| IL297773B2 (en) | 2014-11-17 | 2024-07-01 | Adicet Bio Inc | Engineered gamma delta t-cells |
| AU2016274633B2 (en) * | 2015-06-09 | 2022-04-21 | Gammadelta Therapeutics Ltd | Methods for the production of TCR gamma delta+ T cells |
| HK1255161A1 (zh) | 2015-07-15 | 2019-08-09 | Juno Therapeutics, Inc. | 用於过继性细胞治疗的工程细胞 |
| US11299708B2 (en) | 2016-05-12 | 2022-04-12 | Adicet Bio, Inc. | Methods for selective expansion of γδ T-cell populations and compositions thereof |
-
2018
- 2018-11-15 MX MX2020005005A patent/MX2020005005A/es unknown
- 2018-11-15 SG SG11202004506WA patent/SG11202004506WA/en unknown
- 2018-11-15 CA CA3082818A patent/CA3082818A1/en active Pending
- 2018-11-15 KR KR1020207016650A patent/KR20200098518A/ko not_active Ceased
- 2018-11-15 CN CN201880085549.1A patent/CN111801349A/zh active Pending
- 2018-11-15 US US16/764,796 patent/US12221480B2/en active Active
- 2018-11-15 EP EP18825814.9A patent/EP3710472A1/en active Pending
- 2018-11-15 AU AU2018370120A patent/AU2018370120C1/en active Active
- 2018-11-15 WO PCT/US2018/061384 patent/WO2019099744A1/en not_active Ceased
- 2018-11-15 JP JP2020526478A patent/JP2021502816A/ja active Pending
- 2018-11-15 IL IL274640A patent/IL274640B2/en unknown
-
2020
- 2020-05-25 ZA ZA2020/03097A patent/ZA202003097B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102618231B1 (ko) | 변형된 만능성 줄기 세포, 및 제조 및 사용 방법 | |
| JP5184732B2 (ja) | Ｔ細胞亜集団に特異的なモノクローナル抗体およびポリクローナル抗体の組成物および使用方法 | |
| JP2017535292A5 (https=) | ||
| TW202140530A (zh) | 前列腺特異性膜抗原car及其使用方法 | |
| CN111566201A (zh) | 使用用于表达嵌合抗原受体(car)或转基因t细胞受体(tcr)的病毒载体转导细胞的方法 | |
| EP4545639A2 (en) | Engineered gamma delta t-cells | |
| CN112912494A (zh) | γ-δT细胞和自然杀伤细胞的治疗制剂以及制造和使用方法 | |
| US20200353004A1 (en) | Regulatory T Cell Expressing a Chimeric Antigen Receptor | |
| US20120315269A1 (en) | Immunoglobulin-like transcript (ilt) receptors as cd8 antagonists | |
| CN104884095A (zh) | Cart19用于耗减正常b细胞以诱导耐受的用途 | |
| JP2024527559A5 (https=) | ||
| JP2021502816A5 (https=) | ||
| CN108138148A (zh) | T细胞的激活和扩增 | |
| WO2019154313A1 (zh) | 一种分离的嵌合抗原受体以及包含其的修饰t细胞及用途 | |
| US11697677B2 (en) | Chimeric molecules providing targeted costimulation for adoptive cell therapy | |
| US20240197873A1 (en) | Modified tumor-infiltrating lymphocyte and use thereof | |
| CN118891290A (zh) | 细胞免疫疗法的组合物和方法 | |
| CN110819596A (zh) | 具有增强的迁移能力的修饰的细胞 | |
| AU727955B2 (en) | Cellular vaccines and immunotherapeutics and methods for their preparation | |
| Lankester et al. | Will post-transplantation cell therapies for pediatric patients become standard of care? | |
| WO2024193714A1 (zh) | 细胞免疫疗法的组合物和方法 | |
| EP4714981A1 (en) | Immune effector cell and use thereof | |
| WO2025213573A1 (zh) | 细胞免疫疗法的组合物和方法 | |
| WO2024130179A1 (en) | T cell receptors binding hpv-16 epitopes | |
| WO2025011575A1 (zh) | 细胞免疫疗法的组合物和方法 |